Cargando…

The lung in paracoccidioidomycosis: new insights into old problems

OBJECTIVES: Chronic paracoccidioidomycosis can diffusely affect the lungs. Even after antifungal therapy, patients may present with residual respiratory abnormalities due to fungus-induced lung fibrosis. METHODS: A cross-sectional analysis of 50 consecutive inactive, chronic paracoccidioidomycosis p...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Andre Nathan, Benard, Gil, Albuquerque, Andre Luis Pereira, Fujita, Carmem Lucia, Magri, Adriana Satie Kono, Salge, João Marcos, Shikanai-Yasuda, Maria Aparecida, Carvalho, Carlos Roberto Ribeiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634967/
https://www.ncbi.nlm.nih.gov/pubmed/23778339
http://dx.doi.org/10.6061/clinics/2013(04)02
_version_ 1782267172507090944
author Costa, Andre Nathan
Benard, Gil
Albuquerque, Andre Luis Pereira
Fujita, Carmem Lucia
Magri, Adriana Satie Kono
Salge, João Marcos
Shikanai-Yasuda, Maria Aparecida
Carvalho, Carlos Roberto Ribeiro
author_facet Costa, Andre Nathan
Benard, Gil
Albuquerque, Andre Luis Pereira
Fujita, Carmem Lucia
Magri, Adriana Satie Kono
Salge, João Marcos
Shikanai-Yasuda, Maria Aparecida
Carvalho, Carlos Roberto Ribeiro
author_sort Costa, Andre Nathan
collection PubMed
description OBJECTIVES: Chronic paracoccidioidomycosis can diffusely affect the lungs. Even after antifungal therapy, patients may present with residual respiratory abnormalities due to fungus-induced lung fibrosis. METHODS: A cross-sectional analysis of 50 consecutive inactive, chronic paracoccidioidomycosis patients was performed using high resolution computed tomography, pulmonary function tests, ergospirometry, the six-minute walk test and health-related quality of life questionnaires. RESULTS: Radiological abnormalities were present in 98% of cases, the most frequent of which were architectural distortion (90%), reticulate and septal thickening (88%), centrilobular and paraseptal emphysema (84%) and parenchymal bands (74%). Patients typically presented with a mild obstructive disorder and a mild reduction in diffusion capacity with preserved exercise capacity, including VO(2)max and six-minute walking distance. Patient evaluation with the Saint-George Respiratory Questionnaire showed low impairment in the health-related quality of life, and the Medical Research Council questionnaire indicated a low dyspnea index. There were, however, patients with significant oxygen desaturation upon exercise that was associated with respiratory distress compared with the non-desaturated patients. The initial counterimmunoelectrophoresis of these patients was higher and lung emphysema was more prominent; however, there were no differences in the interstitial fibrotic tomographic abnormalities, tobacco exposure, functional responses, exercise capacity or quality of life. CONCLUSIONS: Inactive, chronic paracoccidioidomycosis patients show persistent and disseminated radiological abnormalities by high resolution computed tomography, short impairments in pulmonary function and low impacts on aerobic capacity and quality of life. However, there was a subset of individuals whose functional impairment was more severe. These patients present with higher initial serology and more severe emphysema, stressing the importance of adequate treatment associated with tobacco exposure cessation.
format Online
Article
Text
id pubmed-3634967
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-36349672013-04-25 The lung in paracoccidioidomycosis: new insights into old problems Costa, Andre Nathan Benard, Gil Albuquerque, Andre Luis Pereira Fujita, Carmem Lucia Magri, Adriana Satie Kono Salge, João Marcos Shikanai-Yasuda, Maria Aparecida Carvalho, Carlos Roberto Ribeiro Clinics (Sao Paulo) Clinical Science OBJECTIVES: Chronic paracoccidioidomycosis can diffusely affect the lungs. Even after antifungal therapy, patients may present with residual respiratory abnormalities due to fungus-induced lung fibrosis. METHODS: A cross-sectional analysis of 50 consecutive inactive, chronic paracoccidioidomycosis patients was performed using high resolution computed tomography, pulmonary function tests, ergospirometry, the six-minute walk test and health-related quality of life questionnaires. RESULTS: Radiological abnormalities were present in 98% of cases, the most frequent of which were architectural distortion (90%), reticulate and septal thickening (88%), centrilobular and paraseptal emphysema (84%) and parenchymal bands (74%). Patients typically presented with a mild obstructive disorder and a mild reduction in diffusion capacity with preserved exercise capacity, including VO(2)max and six-minute walking distance. Patient evaluation with the Saint-George Respiratory Questionnaire showed low impairment in the health-related quality of life, and the Medical Research Council questionnaire indicated a low dyspnea index. There were, however, patients with significant oxygen desaturation upon exercise that was associated with respiratory distress compared with the non-desaturated patients. The initial counterimmunoelectrophoresis of these patients was higher and lung emphysema was more prominent; however, there were no differences in the interstitial fibrotic tomographic abnormalities, tobacco exposure, functional responses, exercise capacity or quality of life. CONCLUSIONS: Inactive, chronic paracoccidioidomycosis patients show persistent and disseminated radiological abnormalities by high resolution computed tomography, short impairments in pulmonary function and low impacts on aerobic capacity and quality of life. However, there was a subset of individuals whose functional impairment was more severe. These patients present with higher initial serology and more severe emphysema, stressing the importance of adequate treatment associated with tobacco exposure cessation. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2013-04 /pmc/articles/PMC3634967/ /pubmed/23778339 http://dx.doi.org/10.6061/clinics/2013(04)02 Text en Copyright © 2013 Hospital das Clínicas da FMUSP http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Science
Costa, Andre Nathan
Benard, Gil
Albuquerque, Andre Luis Pereira
Fujita, Carmem Lucia
Magri, Adriana Satie Kono
Salge, João Marcos
Shikanai-Yasuda, Maria Aparecida
Carvalho, Carlos Roberto Ribeiro
The lung in paracoccidioidomycosis: new insights into old problems
title The lung in paracoccidioidomycosis: new insights into old problems
title_full The lung in paracoccidioidomycosis: new insights into old problems
title_fullStr The lung in paracoccidioidomycosis: new insights into old problems
title_full_unstemmed The lung in paracoccidioidomycosis: new insights into old problems
title_short The lung in paracoccidioidomycosis: new insights into old problems
title_sort lung in paracoccidioidomycosis: new insights into old problems
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634967/
https://www.ncbi.nlm.nih.gov/pubmed/23778339
http://dx.doi.org/10.6061/clinics/2013(04)02
work_keys_str_mv AT costaandrenathan thelunginparacoccidioidomycosisnewinsightsintooldproblems
AT benardgil thelunginparacoccidioidomycosisnewinsightsintooldproblems
AT albuquerqueandreluispereira thelunginparacoccidioidomycosisnewinsightsintooldproblems
AT fujitacarmemlucia thelunginparacoccidioidomycosisnewinsightsintooldproblems
AT magriadrianasatiekono thelunginparacoccidioidomycosisnewinsightsintooldproblems
AT salgejoaomarcos thelunginparacoccidioidomycosisnewinsightsintooldproblems
AT shikanaiyasudamariaaparecida thelunginparacoccidioidomycosisnewinsightsintooldproblems
AT carvalhocarlosrobertoribeiro thelunginparacoccidioidomycosisnewinsightsintooldproblems
AT costaandrenathan lunginparacoccidioidomycosisnewinsightsintooldproblems
AT benardgil lunginparacoccidioidomycosisnewinsightsintooldproblems
AT albuquerqueandreluispereira lunginparacoccidioidomycosisnewinsightsintooldproblems
AT fujitacarmemlucia lunginparacoccidioidomycosisnewinsightsintooldproblems
AT magriadrianasatiekono lunginparacoccidioidomycosisnewinsightsintooldproblems
AT salgejoaomarcos lunginparacoccidioidomycosisnewinsightsintooldproblems
AT shikanaiyasudamariaaparecida lunginparacoccidioidomycosisnewinsightsintooldproblems
AT carvalhocarlosrobertoribeiro lunginparacoccidioidomycosisnewinsightsintooldproblems